|

Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas

RECRUITINGSponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna
Actively Recruiting
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Started2025-05
Est. completion2025-10
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06806488

Summary

This is a purely retrospective and observational monocentric study

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Marginal zone lymphoma patients who were diagnosed and treated in our Hospital between December 2012 and December 2018.
2. Age ≥ 18 years at enrolment.
3. Written informed consent (if applicable)

Exclusion Criteria:

* none

Conditions2

CancerMarginal Zone B-Cell Lymphoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.